全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Primary Hyperparathyroidia at the Abass Ndao Hospital Center: About 29 Cases

DOI: 10.4236/ojim.2023.134037, PP. 427-435

Keywords: Primary Hyperparathyroidism, Hypercalcemia, Parathormone, Osteoporosis, Dakar

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: In Senegal, there is very little data on primary hyperparathyroidism despite an overall upward epidemiological trend. The objective was to describe its epidemiological, clinical, therapeutic and evolutionary aspects. Materials and Methods: This was a cross-sectional, descriptive study, conducted over 5 years (from January 01, 2018 to December 31, 2022) at the National Abass Ndao Hospital Center and including all confirmed cases of primary hyperparathyroidism. Results: Twenty-nine patients were included with a female predominance (86.20%) and an average age of 48.10 ± 18.93 years. The discovery of hyperparathyroidism was fortuitous in 79.31% of cases. The main clinical manifestations were osteoarticular (62%) and urinary (34.5%). On average, serum calcium measured was 109.2 ± 7.92 mg/l, corrected serum calcium 111.3 ± 6.25 mg/l, urinary calcium 421.9 ± 96.45 mg/24h and parathormone at 145 ± 159.71 pg/ml. Among the patients, 25 had hypercalcemia (86.2%) and all had 24-hour hypercalciuria. The diagnosis was retained in view of the elevated parathyroid hormone (PTH) values in all patients. Cervical ultrasound objectified a parathyroid adenoma in 27.58% of cases and 12 patients or 46.2% had presented a scintigraphy in favor of a parathyroid adenoma. We found 01 cases of multiple endocrine neoplasia type 2. Bone densitometry performed in 10 patients found osteoporosis in 60% of cases (6 patients) and osteopenia in 40% of cases (4 patients). Surgical treatment was performed in 12 patients (41.4%). The histology of the surgical specimens was in favor of a parathyroid adenoma in all cases. Among the operated patients, the evolution was marked by a cure rate of 100%. Conclusion: The symptomatology of primary hyperparathyroidism remains mainly osteoarticular and urinary. Surgery has proven its effectiveness in our series. We insist on the systematic dosage of calcemia especially in women over 50 years and the promotion of morphological explorations.

References

[1]  Calzada-Nocaudie, M., Chanson, P., Tabarin, A., et al. (2006) Prise en charge de l’hyperparathyroïdie primaire asymptomatique: Consensus d’experts de la SFE. Annales d’Endocrinologie, 67, 7-12.
https://doi.org/10.1016/S0003-4266(06)72533-1
[2]  Rapado, A. (1986) Arterial Hypertension and Primary Hyperparathyroidism: Incidence and Follow-Up after Parathyroidectomy. American Journal of Nephrology, 6, 49-50.
https://doi.org/10.1159/000167216
[3]  Garnero, P., Gineyts, E., Riou, J.P. and Delmas, P.D. (1994) Assessment of Bone Resorption with a New Marker of Collagen Degradation in Patients with Metabolic Bone Disease. The Journal of Clinical Endocrinology & Metabolism, 79, 780-785.
https://doi.org/10.1210/jcem.79.3.8077361
[4]  Solomon, B.L., Schaaf, M. and Smallridge, R.C. (1994) Psychologic Symptoms before and after Parathyroid Surgery. The American Journal of Medicine, 96, 101-106.
https://doi.org/10.1016/0002-9343(94)90128-7
[5]  Niasse, M., Foufouo, N.V., Diouf, C., et al. (2016) Hyperparathyroïdie Primaire: étude de 22 observations au Sénégal. Revue Marocaine de Rhumatologie, 46, 36-41.
[6]  Eastell, R., Brandi, M.L., Costa, A.G., et al. (2014) Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop. The Journal of Clinical Endocrinology & Metabolism, 99, 3570-3579.
https://doi.org/10.1210/jc.2014-1414
[7]  Bilezikian, J.P., Brandi, M.L., Eastell, R., et al. (2014) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. The Journal of Clinical Endocrinology & Metabolism, 99, 3561-3569.
https://doi.org/10.1210/jc.2014-1413
[8]  Fuleihan, G.E., Gundberg, C.M., Gleason, R., et al. (1994) Racial Differences in Parathyroid Hormone Dynamics. The Journal of Clinical Endocrinology & Metabolism, 79, 1642-1647.
https://doi.org/10.1210/jcem.79.6.7989469
[9]  Hariga, I., Zribi, S., Khamassi, K., et al. (2007) Prise en charge de l’hyperparathyroïdie primaire: à propos de 25 cas et revue de la littérature. Journal Tunisien d’ORL et de Chirurgie Cervico-Faciale, 19, 6-9.
https://doi.org/10.4314/jtdorl.v19i1.57878
[10]  Dia, A.D., Leye, A., Diallo, S., et al. (2015) Primary Hyperparathyroidism in Dakar: Diagnostic and Therapeutic Aspects. Médecine d’Afrique noire, 6202, 77-82.
[11]  Diamond, T.H., Botha, J.R., Vermaak, W.J. and Kalk, W.J. (1987) Hypercalcaemia in Johannesburg Hospital. Differential Diagnosis and Physician Awareness of Primary Hyperparathyroidism. South African Medical Journal, 18, 113-115.
[12]  Adami, S., Marocci, C. and Gatti, D. (2002) Epidemiology of Primary Hyperparathyroidism in Europe. Journal of Bone and Mineral Research, 17, 18-22.
[13]  Cormier, C. (2012) Hyperparathyroïdie Primitive. Revue du Rhumatisme Monographies, 79, 233-238.
https://doi.org/10.1016/j.monrhu.2012.07.002
[14]  Houillier, P. and Muruani, G. (2007) Hyperparathyroidie Primitive. La Revue du praticien, 57, 933-942
[15]  Maruani, G., Cornière, N., Nicoleta, L., Baron, S. and Courbebaisse, M. (2013) Hyperparathyroidie Primitive. La Revue de Médecine Interne, 34, 605-613.
https://doi.org/10.1016/j.revmed.2012.10.369
[16]  Mazzaglia, P.J., Berber, E., Kovach, A., Milas, M., Esselstyn, C. and Siperstein, A.E. (2008) The Changing Presentation of Hyperparathyroidism over 3 Decades. The Archives of Surgery, 143, 260-266.
https://doi.org/10.1001/archsurg.143.3.260
[17]  Maruani, G., Hertig, A., Paillard, M., et al. (2003) Normocalcemic Primary Hyperparathyroidism: Evidence for a Generalized Target-Tissue Resistance to Parathyroid Hormone. The Journal of Clinical Endocrinology & Metabolism, 88, 4641-4648.
https://doi.org/10.1210/jc.2002-021404
[18]  Ljunghall, S., Larsson, K., Lindh, E., et al. (1991) Disturbance of Basal and Stimulated Serum Levels of Intact Parathyroid Hormone in Primary Hyperparathyroidism. Surgery, 110, 47-53.
[19]  Velayoudom, C., Fritz, L., Foucan, L., et al. (2011) La moitié des patients atteints d’hyperparathyroïdies primaires ont un déficit en vitamine D aggravant l’atteinte osseuse. La Presse Médicale, 40, 120-127.
https://doi.org/10.1016/j.lpm.2010.08.005
[20]  Giron, J., Ouhayoun, E., Dahan, M., et al. (1996) Imaging of Hyperparathyroidism: US, CT, MRI and MIBI Scintigraphy. European Journal of Radiology, 21, 167-173.
https://doi.org/10.1016/0720-048X(95)00711-X
[21]  Boccalatte, L.A., Higuera, F., Gómez, N.L., et al. (2019) Usefulness of 18F-Fluorocholine Positron Emission Tomography-Computed Tomography in Locating Lesions in Hyperparathyroidism: A Systematic Review. JAMA Otolaryngology—Head & Neck Surgery, 145, 743-750.
https://doi.org/10.1001/jamaoto.2019.0574
[22]  Silva, B.C., Cusano, N.E. and Bilezikian, J.P. (2018) Primary Hyperparathyroidism. Best Practice & Research Clinical Endocrinology & Metabolism, 32, 593-607.
https://doi.org/10.1016/j.beem.2018.09.004
[23]  Lahiani, R., Khamassi, K., Dhaouadi, A., et al. (2010) Diagnostic et prise en charge de l’hyperparathyroïdie primaire. Journal tunisien d’ORL et de chirurgie cervicofaciale, 25, 21-26.
[24]  Zitouni, S., Bouzbid, S., Bouchair, A., et al. (2013) Chirurgie de l’hyperparathyroïdie primaire: Notre expérience. Annales Fran?aises D’Oto-Rhino-Laryngologie et de Pathologie Cervico-Faciale, 130, A19-A20.
https://doi.org/10.1016/j.aforl.2013.06.048
[25]  Nsame, D., Chadli, A., El Aziz, S., et al. (2014) Hyperparathyroïdies Primitives, à propos de 60 cas. Annales d’Endocrinologie, 75, 349.
https://doi.org/10.1016/j.ando.2014.07.264

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133